Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 6/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.39 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | SCN4A | P35499 | 1/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | PRCP | P42785 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Proline SCHEMBL16394427 | 0.84 | BLM (0.48) | MEN1BLMKMT2ADPP4DPP8 | |
| Proline SCHEMBL10141185 | 0.84 | — | — | |
| Proline SCHEMBL462226 | 0.84 | BLM (0.52) | MEN1BLMKMT2ADPP4DPP8 | |
| Proline SCHEMBL6894672 | 0.84 | BLM (0.52) | MEN1BLMKMT2ADPP4DPP8 | |
| Proline SCHEMBL718906 | 0.84 | BLM (0.52) | MEN1BLMKMT2ADPP4DPP8 | |
| Proline SCHEMBL10141181 | 0.84 | — | — | |
| Proline SCHEMBL2939 | 0.84 | — | — | |
| Proline SCHEMBL13248912 | 0.84 | — | — | |
| D-Proline SCHEMBL21462052 | 0.84 | BLM (0.52) | MEN1BLMKMT2ADPP4DPP8 | |
| Proline SCHEMBL462225 | 0.84 | BLM (0.52) | MEN1BLMKMT2ADPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1953763-A | Y4 selective receptor agonists for therapeutic intervention | 7TM PHARMA AS (DK) | 2007-04-25 | — | — | CN | claimed |
| CN-105228642-A | Compositions and methods for inhibiting tumor cells by inhibiting transcription factor ATF5 | TRUSTEES OF COLUMBIA UNVERSITY IN THE CITY OF NEW YORK | 2016-01-06 | — | — | CN | disclosed |
| CN-101035568-A | Combination therapy using transferrin fusion proteins comprising GLP-1 | BIOREXIS PHARMACEUTICAL CORP (US) | 2007-09-12 | — | — | CN | disclosed |
| CN-1953763-A | Y4 selective receptor agonists for therapeutic intervention | 7TM PHARMA AS (DK) | 2007-04-25 | — | — | CN | disclosed |
| CN-1933848-A | Y2 selective receptor agonists for therapeutic intervention | 7TM PHARMA AS (DK) | 2007-03-21 | — | — | CN | disclosed |